Thursday, April 06, 2017 7:35:26 PM
http://s1.q4cdn.com/460208960/files/News/2017/April-4-2017_CASI_Zeng.pdf
A Zachs PR titled "CASI Exited Fiscal 2016 with a Strong Balance Sheet" came out the same day. Funny how CASI tanked today w everything going good as it looks like if one read the Analyst report. Just goes to show you that until CASI starts making money it's at the mercy of money managers. Anyhows, it talks of when Evomela, Marqibo, and Zevalin will be approved in China as well as what's going on w CASIs drug ENMD-2076 prospects in FLC. Definitely worth reading.
Recent SPPI News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 11/09/2023 10:00:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/28/2023 04:15:27 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 09/26/2023 09:23:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM